about
Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneuronsEfficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis.Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats.Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic painCR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.Experimental pharmacology of glucosamine sulfate.Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity.Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation.Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex.Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.Cognition Enhancing Profile of CR 2249, a New NMDA-Glycine Site ModulatorDevelopment of subnanomolar-affinity serotonin 5-HT receptor ligands based on quinoline structuresDendrimeric tetravalent ligands for the serotonin-gated ion channelMultivalent ligands for the serotonin 5-HT receptorImproved efficacy, tolerance, safety and abuse liability profile of the combination CR4056-morphine over morphine alone in rodent modelsCR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons
P50
Q28143514-1352C33A-43BA-407E-96B8-607104CACAA2Q33650279-43864340-28B4-4D8D-9E33-6821A74C3268Q34025170-4BCDE412-D49F-4216-ABF1-BF8478602507Q34999759-DA839370-1DA2-46C1-A3F7-7F578B4B33A7Q36084704-C77F86F7-560E-46D4-9F84-3BB5CEBFBDE0Q38684643-B29E7A75-42E4-460D-957F-07983C09FE6AQ39778292-1605E95F-0EE9-4720-85AA-AA795AA984DAQ40290440-46A8131A-57E6-4DBB-89AA-0C317D1F45ABQ42712600-D82CB226-5E4D-447F-A3B1-451FA5D4EA14Q46763265-71D8D08C-8537-4332-91E8-3330EFD2E86AQ48265619-DC0E3218-D2CF-4291-BA28-AF6A451B2A10Q52680975-DDD62BE8-74CB-4A57-A6EB-CDD37A9D61ABQ53842126-9912E11E-86C8-47CF-9C4D-D6CCA98F6315Q55981215-D7AED508-2CD8-4B59-B2B8-22E4B707D6E7Q57139847-DD756FEC-351D-43B5-8A7B-966CC1599829Q59613729-4EB0EB61-1745-43BC-8C92-4347050A29B0Q60513791-4B239247-B526-4CD4-A880-73A300F0C71BQ90185275-6C373CD5-A684-4283-BFFC-EAB0D75004EBQ92901736-AD26262A-0220-493C-9BB1-50E87F85168F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Lanza
@ast
Marco Lanza
@en
Marco Lanza
@es
Marco Lanza
@nl
Marco Lanza
@sl
type
label
Marco Lanza
@ast
Marco Lanza
@en
Marco Lanza
@es
Marco Lanza
@nl
Marco Lanza
@sl
prefLabel
Marco Lanza
@ast
Marco Lanza
@en
Marco Lanza
@es
Marco Lanza
@nl
Marco Lanza
@sl
P106
P1153
7102063231
P21
P31
P496
0000-0001-7264-6386